A new quantitative PCR for human parvovirus B19 genotypes

Journal of Virological Methods

Volumn 218, Issue , 2015, Pages 40-45

  Toppinen, M ^a   Norja, P ^a   Aaltonen, L M ^b   Wessberg, S ^c   Hedman, L ^a,b   Soderlund Venermo M ^a   Hedman, K ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

B19V; Genotyping; Parvovirus; QPCR

Indexed keywords

NONSTRUCTURAL PROTEIN 1; VIRUS DNA; NS1 PROTEIN, PARVOVIRUS; VIRUS PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA TEMPLATE; GENE DOSAGE; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; INFANT; MEASUREMENT REPEATABILITY; MIDDLE AGED; NONHUMAN; NS1 GENE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCHOOL CHILD; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VALIDATION PROCESS; VIRUS GENOME; YOUNG ADULT; CLASSIFICATION; ERYTHEMA INFECTIOSUM; GENETICS; PALATINE TONSIL; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TONSILLITIS; VIROLOGY;

PARVOVIRUS; SSDNA VIRUSES;

DNA, VIRAL; ERYTHEMA INFECTIOSUM; HUMANS; PALATINE TONSIL; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TONSILLITIS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84925710883     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.03.006     Document Type: Article

References (54)

1. Adamson L.A., Fowler L.J., Ewald A.S., Clare-Salzler M.J., Hobbs J.A. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J. Med. Virol. 2014, 86:1614-1620.
2. Anderson M.J., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A. Experimental parvoviral infection in humans. J. Infect. Dis. 1985, 152:257-265.
3. Anderson M.J., Lewis E., Kidd I.M., Hall S.M., Cohen B.J. An outbreak of erythema infectiosum associated with human parvovirus infection. J. Hyg. (Lond) 1984, 93:85-93.
4. Astell C.R., Blundell M.C. Sequence of the right hand terminal palindrome of the human B19 parvovirus genome has the potential to form a 'stem plus arms' structure. Nucleic Acids Res. 1989, 17:5857.
5. Baylis S.A., Ma L., Padley D.J., Heath A.B., Yu M.W., Collaborative Study Group Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang. 2012, 102:204-211.
6. Baylis S.A., Shah N., Minor P.D. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J. Virol. Methods 2004, 121:7-16.
7. Blümel J., Eis-Hübinger A.M., Stuhler A., Bonsch C., Gessner M., Lower J. Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells. J. Virol. 2005, 79:14197-14206.
8. Bock C.T., Klingel K., Kandolf R. Human parvovirus B19-associated myocarditis. N. Engl. J. Med. 2010, 362:1248-1249.
9. Bonvicini F., Manaresi E., Bua G., Venturoli S., Gallinella G. Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay. J. Clin. Microbiol. 2013, 51:3753-3759.
10. Brown T., Anand A., Ritchie L.D., Clewley J.P., Reid T.M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984, 2:1033-1034.
11. Bültmann B.D., Klingel K., Sotlar K., Bock C.T., Baba H.A., Sauter M., Kandolf R. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum. Pathol. 2003, 34:92-95.
12. Candotti D., Etiz N., Parsyan A., Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 2004, 78:12169-12178.
13. Chevrel G., Calvet A., Belin V., Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology (Oxford) 2000, 39:1037-1039.
14. Corcioli F., Zakrzewska K., Rinieri A., Fanci R., Innocenti M., Civinini R., De Giorgi V., Di Lollo S., Azzi A. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J. Med. Virol. 2008, 80:2005-2011.
15. Cossart Y.E., Cant B., Field A.M., Widdows D. Parvovirus-like particles in human sera. Lancet 1975, 1:72-73.
16. Cotmore S.F., Agbandje-McKenna M., Chiorini J.A., Mukha D.V., Pintel D.J., Qiu J., Söderlund-Venermo M., Tattersall P., Tijssen P., Gatherer D., Davison A.J. The family Parvoviridae. Arch. Virol. 2014, 159:1239-1247.
17. Cotmore S.F., Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science 1984, 226:1161-1165.
18. Deiss V., Tratschin J.D., Weitz M., Siegl G. Cloning of the human Parvovirus-B19 genome and structural-analysis of its palindromic termini. Virology 1990, 175:247-254.
19. Doerig C., Beard P., Hirt B. A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 1987, 157:539-542.
20. Ekman A., Hokynar K., Kakkola L., Kantola K., Hedman L., Bondén H., Gessner M., Aberham C., Norja P., Miettinen S., Hedman K., Söderlund-Venermo M. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J. Virol. 2007, 81:6927-6935.
21. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., Lankinen H., Hedman L., Söderlund-Venermo M., Hedman K. Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics. J. Clin. Virol. 2006, 35:400-406.
22. Freitas R.B., Melo F.L., Oliveira D.S., Romano C.M., Freitas M.R., Macedo O., Linhares A.C., de A Zanotto P.M., Durigon E.L. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil. J. Clin. Virol. 2008, 43:60-65.
23. Gray A., Guillou L., Zufferey J., Rey F., Kurt A.M., Jichlinski P., Leisinger H.J., Benhattar J. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours. J. Gen. Virol. 1998, 79(Pt 3):573-579.
24. Hokynar K., Norja P., Laitinen H., Palomäki P., Garbarg-Chenon A., Ranki A., Hedman K., Söderlund-Venermo M. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J. Clin. Microbiol. 2004, 42:2013-2019.
25. Hokynar K., Söderlund-Venermo M., Pesonen M., Ranki A., Kiviluoto O., Partio E.K., Hedman K. A new parvovirus genotype persistent in human skin. Virology 2002, 302:224-228.
26. Jain P., Jain A., Prakash S., Khan D.N., Singh D.D., Kumar A., Moulik N.R., Chandra T. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India. J. Med. Virol. 2015, 87:303-309.
27. Kaikkonen L., Söderlund-Venermo M., Brunstein J., Schou O., Panum Jensen I., Rousseau S., Caul E.O., Cohen B., Valle M., Hedman L., Hedman K. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J. Med. Virol. 2001, 64:360-365.
28. Knott P.D., Welply G.A., Anderson M.J. Serologically proved intrauterine infection with parvovirus. Br. Med. J. (Clin. Res. Ed.) 1984, 289:1660.
29. Kuethe F., Lindner J., Matschke K., Wenzel J.J., Norja P., Ploetze K., Schaal S., Kamvissi V., Bornstein S.R., Schwanebeck U., Modrow S. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin. Infect. Dis. 2009, 49:1660-1666.
30. Kurtzman G.J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N.S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N. Engl. J. Med. 1987, 317:287-294.
31. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.S., Raab U., Neumayer H.H., Meisel H., Modrow S. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J. Med. Virol. 2005, 75:161-169.
32. Lindblom A., Isa A., Norbeck O., Wolf S., Johansson B., Broliden K., Tolfvenstam T. Slow clearance of human parvovirus B19 viremia following acute infection. Clin. Infect. Dis. 2005, 41:1201-1203.
33. Manning A., Willey S.J., Bell J.E., Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J. Infect. Dis. 2007, 195:1345-1352.
34. Maple P.A., Hedman L., Dhanilall P., Kantola K., Nurmi V., Söderlund-Venermo M., Brown K.E., Hedman K. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. J. Clin. Microbiol. 2014, 52:947-956.
35. McNees A.L., White Z.S., Zanwar P., Vilchez R.A., Butel J.S. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 2005, 34:52-62.
36. Mori K., Munakata Y., Saito T., Tani J., Nakagawa Y., Hoshikawa S., Ozaki H., Ito S., Yoshida K. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J. Infect. 2007, 55:e29-e31.
37. Musiani M., Zerbini M., Gentilomi G., Plazzi M., Gallinella G., Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J. Infect. Dis. 1995, 172:1360-1363.
38. Nguyen Q.T., Sifer C., Schneider V., Allaume X., Servant A., Bernaudin F., Auguste V., Garbarg-Chenon A. Novel human erythrovirus associated with transient aplastic anemia. J. Clin. Microbiol. 1999, 37:2483-2487.
39. Nguyen Q.T., Wong S., Heegaard E.D., Brown K.E. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 2002, 301:374-380.
40. Norja P., Hokynar K., Aaltonen L.M., Chen R., Ranki A., Partio E.K., Kiviluoto O., Davidkin I., Leivo T., Eis-Hübinger A.M., Schneider B., Fischer H.-P., Tolba R., Vapalahti O., Vaheri A., Söderlund-Venermo M., Hedman K. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7450-7453.
41. Ozawa K., Ayub J., Hao Y.S., Kurtzman G., Shimada T., Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 1987, 61:2395-2406.
42. Ozawa K., Young N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 1987, 61:2627-2630.
43. Rinckel L.A., Buno B.R., Gierman T.M., Lee D.C. Discovery and analysis of a novel parvovirus B19 genotype 3 isolate in the United States. Transfusion (Paris) 2009, 49:1488-1492.
44. Sadeghi M., Aaltonen L.M., Hedman L., Chen T., Söderlund-Venermo M., Hedman K. Detection of TS polyomavirus DNA in tonsillar tissues of children and adults: evidence for site of viral latency. J. Clin. Virol. 2014, 59:55-58.
45. Sanabani S., Neto W.K., Pereira J., Sabino E.C. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J. Clin. Microbiol. 2006, 44:604-606.
46. Schenk T., Enders M., Pollak S., Hahn R., Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J. Clin. Microbiol. 2009, 47:106-110.
47. Schmidt I., Blümel J., Seitz H., Willkommen H., Lower J. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang. 2001, 81:228-235.
48. Schneider B., Hone A., Tolba R.H., Fischer H.P., Blümel J., Eis-Hübinger A.M. Simultaneous persistence of multiple genome variants of human parvovirus B19. J. Gen. Virol. 2008, 89:164-176.
49. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J.F., Garbarg-Chenon A. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol. 2002, 76:9124-9134.
50. Siegl G., Cassinotti P. Presence and significance of parvovirus B19 in blood and blood products. Biologicals 1998, 26:89-94.
51. Soucie J.M., De Staercke C., Monahan P.E., Recht M., Chitlur M.B., Gruppo R., Hooper W.C., Kessler C., Kulkarni R., Manco-Johnson M.J., Powell J., Pyle M., Riske B., Sabio H., Trimble S., The US Hemophilia Treatment Center Network Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion 2013, 53(6):1217-1225. Epub 2012 Sep 24. 10.1111/j.1537-2995.2012.03907.x.
52. Söderlund M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997, 349:1063-1065.
53. Tanawattanacharoen S., Falk R.J., Jennette J.C., Kopp J.B. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am. J. Kidney Dis. 2000, 35:1166-1174.
54. Willkommen H., Schmidt I., Lower J. Safety issues for plasma derivatives and benefit from NAT testing. Biologicals 1999, 27:325-331.